2016: A retrospective from the industry
February 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
2016 was characterised by some of the biggest political shifts in recent times. We ask four major pharma figures for …
Pakistan drug regulatory body “a complete failure” according to officials
February 2, 2017Sales and Marketing Drug Regulatory Authority of Pakistan, Pakistan, Sania Nishtar
Key figures in the Pakistani pharmaceutical industry are calling for review of the Drug Regulatory Authority of Pakistan (DRAP) over …
‘Last-resort’ antibiotic-resistant bacteria found along 4km of Chinese coastline
February 2, 2017Medical Communications, Research and Development
Recent research has been published that reveals that a four kilometre stretch of coastline in China harboured bacteria resistant to …
Allergan successfully completes $2.9bn LifeCell acquisition
February 2, 2017Business Services, Sales and Marketing Allergan, LifeCell
The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …
Two-decade-long prostate cancer study finds antiandrogen improves survival
February 2, 2017Research and Development antiandrogen, oncology, prostate cancer
Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …
Genentech oncology head leaves for Bellicum CEO role
February 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bellicum, Genentech, Roche, tecentriq
Bellicum Pharmaceuticals has snatched up Genentech’s Rick Fair as its new CEO and President. Fair moves to Bellicum from Genentech …
MSD’s drug given European approval for first-line treatment in NSCLC
February 1, 2017Sales and Marketing European Commission, MSD, Merck
The good news keeps coming for MSD, known as Merck in North America, and Keytruda, with a further label expansion …
Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection
February 1, 2017Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab
Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …
Potential treatment for opioid withdrawal discovered
February 1, 2017Medical Communications, Research and Development University of Calgary, gout, opioid
Researchers from the University of Calgary have found that medication used to treat gout could also lessen the side-effects experienced …
Italian firm warned by FDA over record-shredding and drug quality misrepresentation
February 1, 2017Manufacturing and Production, Research and Development FACTA Farmaceutici, FDA
Italian drug manufacturer FACTA Farmaceutici has been issued a warning letter by the FDA after being found shredding “critical laboratory …
African Heads of State commit to universal access to immunisation
February 1, 2017Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation
The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …
Trump meets with top pharma execs, reiterates pledge to lower “astronomical” prices
January 31, 2017Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Eli Lilly, Novartis, PhRMA, Trump
President Trump convened with a number of top pharma execs at the White House on Tuesday to discuss the key …
Antitrust investigation into Mylan begins over EpiPen
January 31, 2017Research and Development, Sales and Marketing Mylan, pricing
The Federal Trade Commission has submitted a request to Mylan for information as part of a preliminary investigation into whether …
First-line malaria treatment fails for the first time in UK
January 31, 2017Manufacturing and Production, Research and Development UK, malaria
The key combination malaria therapy artemether-lumefantrine has failed to treat UK patients for the first time, suggesting that the parasite …
Price-fixing class action lawsuit levelled at three major insulin producers
January 31, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing
A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …
Trump’s “one in, two out” regulatory order threatens FDA, Obama Cures Act
January 31, 2017Manufacturing and Production, Sales and Marketing FDA, Trump
An executive order signed by President Donald Trump on Monday has caused concern in the US pharma industry and beyond …
Teva hit by patent blow upon top-selling MS drug
January 31, 2017Manufacturing and Production Mylan, Teva, generic, multiple sclerosis
Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …
1,100% generic cancer drug price increases fly below UK radar
January 30, 2017Manufacturing and Production, Sales and Marketing Drug pricing, European Cancer congress
If you were asked what the big topic of discussion in the pharmaceutical industry was last year, there would really …
Sanofi announces new VP of External Affairs
January 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi
Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …
Major pharma firms join Liverpool Uni in £14m pharmacovigilance project
January 30, 2017Research and Development, Sales and Marketing AZ, AbbVie, Eli Lilly, GSK, University of Liverpool, pharmacovigilance
The UK’s University of Liverpool is to launch a £14 million pharmacovigilance project focused on using new modelling approaches to …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
